AGBL2

Cytosolic carboxypeptidase 2 · Q5U5Z8 · AGBL2 on Sugi Atlas →

1,832 patent compounds predicted against AGBL2, 647 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL20564977 SCHEMBL20564977 0.51 3/20
SCHEMBL30035128 SCHEMBL30035128 0.51 3/20
SCHEMBL12698841 SCHEMBL12698841 1.00 2/20
SCHEMBL12698842 SCHEMBL12698842 1.00 2/20
SCHEMBL29135531 SCHEMBL29135531 0.71 2/20
SCHEMBL27889652 SCHEMBL27889652 0.69 2/20
SCHEMBL4530478 SCHEMBL4530478 0.69 2/20
SCHEMBL29781576 SCHEMBL29781576 0.69 2/20
SCHEMBL3928210 SCHEMBL3928210 0.68 2/20
SCHEMBL25376066 SCHEMBL25376066 0.65 2/20
Hydrochloric Acid Hydrochloric Acid (SCHEMBL28487392) 0.63 2/20
SCHEMBL15544538 SCHEMBL15544538 0.62 2/20
SCHEMBL13250884 SCHEMBL13250884 0.61 2/20
SCHEMBL25373773 SCHEMBL25373773 0.61 2/20
SCHEMBL17653807 SCHEMBL17653807 0.60 2/20
SCHEMBL16386043 SCHEMBL16386043 0.59 2/20
SCHEMBL16240808 SCHEMBL16240808 0.58 2/20
SCHEMBL2589616 SCHEMBL2589616 0.56 2/20
SCHEMBL26199719 SCHEMBL26199719 0.54 2/20
SCHEMBL27462826 SCHEMBL27462826 0.53 2/20

Clinical trials — most relevant to AGBL2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Pharmacogenomic Evaluation of Antihypertensive Responses PHASE4COMPLETED
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans PHASE1COMPLETED
Screening of Lysosomal Storage Disorders Diseases in Minority Groups nanUNKNOWN
SRT in Comparison to ERT on Immune Aspects and Bone Involvement in Gaucher Disease nanUNKNOWN
Factors Involved in Asthma and Airway Inflammation nanCOMPLETED
Celiac Disease Genomic Environmental Microbiome and Metabolomic Study nanRECRUITING
Epidemiological and Genetic Studies of Body Mass Index nanCOMPLETED
Molecular Epidemiology of Essential Hypertension nanCOMPLETED
Proteogenomic Monitoring and Assessment of Liver Transplant Recipients nanRECRUITING
Catalytic Antibodies to Predict Uninvasively Late Transplant Failure nanCOMPLETED
Identification of Acute Intermittent Porphyria Modifying Genes nanRECRUITING
Role of ADA SNPs in Subjects With Relapsing Multiple Sclerosis (RMS) nanUNKNOWN
PCD New Gene Discovery nanCOMPLETED
Markers and Mechanisms of Macrovascular Disease in IDDM nanCOMPLETED
Family Studies in Primary Biliary Cirrhosis (PBC) nanUNKNOWN
Chromosome 5Q Gene Variants and Asthma-Related Traits nanCOMPLETED
Molecular Genetics Study of Nasopharyngeal Carcinoma: Characterization of NCP Susceptibility Gene(s) nanCOMPLETED
Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST) nanCOMPLETED
The Etiology and Progression of Brain Tumors nanCOMPLETED
Family Blood Pressure Program - GENOA nanCOMPLETED
Family Blood Pressure Program - SAPPHIRe Network nanCOMPLETED
Risk Factors for the Development of Celiac Disease in Genetically Predisposed Children nanUNKNOWN
Identification of Genes Predisposing to Atherosclerosis nanCOMPLETED
The Genetic Characterization of Dementia nanCOMPLETED
Biomarkers of Lichen Sclerosus nanUNKNOWN
Integrated Proteomic HPLC-ESI-MS Analysis of Salivary Peptides of Preterm Newborns: a Pilot Study nanCOMPLETED
Genetic Studies of Lysosomal Storage Disorders nanENROLLING_BY_INVITATION
Clotting Genetic Variants, Hormones, and Venous Thrombosis nanCOMPLETED
Family Blood Pressure Program - HyperGEN nanCOMPLETED
HYPOCHOL : A Genetically-based Strategy to Identify New Targets in Cholesterol Metabolism nanACTIVE_NOT_RECRUITING

Related proteins — ESM-2 sequence neighbours (a AGBL2 binder may also engage these)

ProteinNameSimilarity
Q8CDK2 1.000 Q8CDK2 →
Q8NEM8 0.998 Q8NEM8 →
Q4R632 0.997 Q4R632 →
Q8CDP0 0.997 Q8CDP0 →
Q0P4M4 0.995 Q0P4M4 →
E1B9D8 0.993 E1B9D8 →
B0JZV4 0.993 B0JZV4 →
Q5R978 0.992 Q5R978 →
A6H8T7 0.992 A6H8T7 →
Q6EEF3 0.991 Q6EEF3 →
Q5TKR9 0.990 Q5TKR9 →
A2A3K4 0.989 A2A3K4 →
KAT6B Histone acetyltransferase KAT6B 0.989 landscape →
Q8BZ21 0.989 Q8BZ21 →
MAP3K13 Mitogen-activated protein kinase kinase kinase 13 0.988 landscape →
Q92613 0.988 Q92613 →
Q6ZT98 0.988 Q6ZT98 →
Q68UT7 0.988 Q68UT7 →
E1C2V1 0.988 E1C2V1 →
Q80TF6 0.988 Q80TF6 →
Q6EMB2 0.988 Q6EMB2 →
Q1ECV4 0.988 Q1ECV4 →
Q63553 0.988 Q63553 →
Q3ULB5 0.988 Q3ULB5 →
Q5FWM1 0.988 Q5FWM1 →
A7MBB4 0.987 A7MBB4 →
Q99PI4 0.987 Q99PI4 →
PIKFYVE 1-phosphatidylinositol 3-phosphate 5-kinase 0.987 landscape →
Q1LYM3 0.987 Q1LYM3 →
F4JZ68 0.987 F4JZ68 →